Adelaide Robb
Clinical Neurophysiology · Washington, DCNPI 1033209309
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,050 of the $45,081 with a category attached, or 66.7%. Supernus Pharmaceuticals, Inc. accounts for 60.9% of it on its own, with 8 other manufacturers making up the rest.
Across 107 payments — averaging $421.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$27K
- H. Lundbeck A S$10K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4K
- Janssen Research & Development, LLC$2K
- Axsome Therapeutics, Inc.$2K
- Neurelis, Inc.$123
- plus $175 from 3 others
Across 156 payments — averaging $3497.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acadia Pharmaceuticals Inc$181K
- Supernus Pharmaceuticals, Inc.$127K
- Alkermes, Inc.$108K
- AbbVie$71K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$30K
- H. Lundbeck A S$18K
- plus $11K from 1 others
What the payments were for
- Consulting fees$7,71517%
- Speaking & faculty fees$30,05067%
- Travel & lodging$4,83611%
- Food & beverage$2,4806%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 93 | $27,433 |
| H. Lundbeck A S | 2 | $9,600 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $4,375 |
| Janssen Research & Development, LLC | 2 | $1,875 |
| Axsome Therapeutics, Inc. | 1 | $1,500 |
| Neurelis, Inc. | 1 | $123 |
| UCB, Inc. | 1 | $120 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Alkermes, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$16,132
- BRINTELLIX$9,600
- REXULTI$4,375
- VALTOCO$123
- Briviact$120
How this compares
Too few clinical neurophysiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Other clinical neurophysiology in Washington
- Perry RichardsonWashington$74K
- Jay SalpekarWashington$20K
- Sumanjit KaurWashington$4K
- Mark LinWashington$613
- Thanh NguyenWashington$569
- Jessica StevensWashington$415
- Robert LaurenoWashington$85
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.